Clinical trial reportJournal of medicinal chemistryPublished
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of medicinal chemistry
- Published
- Subject terms
- Animals; Dogs; Humans; Mice; Rats; Antineoplastic Agents; Administration, Oral; Structure-Activity Relationship; Biological Availability; Dose-Response Relationship, Drug; Proto-Oncogene Proteins p21(ras); Drug Discovery
- PubMed ID
- 38924388
- Added to directory
- Source checked